The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial
Open accessAbstract
Background— The use of the Endeavor stent might reduce restenosis and stent thrombosis at 9 months. Methods and Results— Patients (n=1197) treated for single coronary artery stenosis were enrolled in a prospective, randomized, double-blind study and randomly assigned to receive the Endeavor zotarolimus-eluting phosphorylcholine polymer–coated stent (n=598) or the same bare metal stent but without the drug or the polymer coating (n=599). The 2 groups were well matched in baseline characteristics. Diabetes was present in 20.1% of patients; the mean reference vessel diameter was 2.75 mm; and the mean lesion length was 14.2 mm. The primary end point of target vessel failure at 9 months was reduced from 15.1% with the bare metal stent to 7.9% with the Endeavor ( P =0.0001), and the rate of major adverse cardiac events was reduced from 14.4% with the bare metal stent to 7.3% with the Endeavor ( P =0.0001). Target lesion revascularization was 4.6% with Endeavor compared with 11.8% with the bare metal stent ( P =0.0001). The rate of stent thrombosis was 0.5% with the Endeavor, which was not significantly different from 1.2% with the bare metal stent. In 531 patients submitted to angiographic follow-up, late loss was reduced from 1.03±0.58 to 0.61±0.46 ( P <0.001) in stent and from 0.72±0.61 to 0.36±0.46 ( P <0.001) in segment. The rate of in-segment restenosis was reduced from 35.0% to 13.2% with Endeavor ( P <0.0001). There was no excessive edge stenosis, aneurysm formation, or late acquired malapposition by intravascular ultrasound imaging. Differences in clinical outcome were maintained at 12 and 24 months ( P <0.0001). Conclusions— Compared with bare metal stents, the Endeavor stent is safe and reduces the rates of clinical and angiographic restenosis at 9, 12, and 24 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Self-citationIakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Self-citationVirmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
McFadden, E. P., Stabile, E., Regar, E., Cheneau, E., Ong, A. T., Kinnaird, T., Suddath, W. O., Weissman, N. J., Torguson, R., Kent, K. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17275-9 · Cited by 1,436
Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.192 · Cited by 793
Self-citationPredictive Factors of Restenosis After Coronary Stent Placement
Kastrati, A., Schömig, A., Elezi, S., Schühlen, H., Dirschinger, J., Hadamitzky, M., Wehinger, A., Hausleiter, J., Walter, H., & Neumann, F.-J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00334-3 · Cited by 685
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
Babapulle, M. N., Joseph, L., Bélisle, P., Brophy, J. M., & Eisenberg, M. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16850-5 · Cited by 645
Finn, A. V., Kolodgie, F. D., Harnek, J., Guerrero, L. J., Acampado, E., Tefera, K., Skorija, K., Weber, D. K., Gold, H. K., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.508937 · Cited by 556
Vessel Size and Long-Term Outcome After Coronary Stent Placement
Elezi, S., Kastrati, A., Neumann, F.-J., Hadamitzky, M., Dirschinger, J., & Schömig, A. (1998) · Circulation · doi:10.1161/01.cir.98.18.1875 · Cited by 484
Cited by
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Self-citationAuthors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Self-citationGuidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
Urban, P., Mehran, R., Colleran, R., Angiolillo, D. J., Byrne, R. A., Capodanno, D., Cuisset, T., Cutlip, D., Eerdmans, P., Eikelboom, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040167 · Cited by 823
Drug-Eluting Coronary-Artery Stents
Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 728
Ormiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60415-8 · Cited by 712
Self-citationA New Strategy for Discontinuation of Dual Antiplatelet Therapy
Kim, B.-K., Hong, M.-K., Shin, D.-H., Nam, C.-M., Kim, J.-S., Ko, Y.-G., Choi, D., Kang, T.-S., Park, B.-E., Kang, W.-C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.043 · Cited by 646
Urban, P., Mehran, R., Colleran, R., Angiolillo, D. J., Byrne, R. A., Capodanno, D., Cuisset, T., Cutlip, D., Eerdmans, P., Eikelboom, J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz372 · Cited by 621
Gwon, H.-C., Hahn, J.-Y., Park, K. W., Song, Y. B., Chae, I.-H., Lim, D.-S., Han, K.-R., Choi, J.-H., Choi, S.-H., Kang, H.-J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.059022 · Cited by 614
Rapezzi, C., Biagini, E., & Branzi, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm498 · Cited by 595
Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M. J., Feit, F., Bhatt, D. L., & Slater, J. (2012) · Circulation · doi:10.1161/circulationaha.112.097014 · Cited by 574
Garg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.007 · Cited by 501
Sarno, G., Lagerqvist, B., Fröbert, O., Nilsson, J., Olivecrona, G., Omerovic, E., Saleh, N., Venetzanos, D., & James, S. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr479 · Cited by 378
Windecker, S., Stortecky, S., Stefanini, G. G., daCosta, B. R., Rutjes, A. W., Di Nisio, M., Siletta, M. G., Maione, A., Alfonso, F., Clemmensen, P. M., et al. (2014) · BMJ · doi:10.1136/bmj.g3859 · Cited by 356
Self-citationThe Problem With Composite End Points in Cardiovascular Studies
Kip, K. E., Hollabaugh, K., Marroquin, O. C., & Williams, D. O. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.034 · Cited by 348
Kandzari, D. E., Leon, M. B., Popma, J. J., Fitzgerald, P. J., O’Shaughnessy, C., Ball, M. W., Turco, M., Applegate, R. J., Gurbel, P. A., Midei, M. G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.035 · Cited by 347
Self-citationCoronary stents: historical development, current status and future directions
Iqbal, J., Gunn, J., & Serruys, P. W. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt009 · Cited by 319
Hassan, A. K. M., Bergheanu, S. C., Stijnen, T., van der Hoeven, B. L., Snoep, J. D., Plevier, J. W. M., Schalij, M. J., & Wouter Jukema, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehn553 · Cited by 290
Metadata
- Authors
- Fajadet, J., Wijns, W., Laarman, G.-J., Kuck, K.-H., Ormiston, J., Münzel, T., Popma, J. J., Fitzgerald, P. J., Bonan, R., & Kuntz, R. E.
- Venue
- Circulation
- Published
- 2006-08-22
- Volume
- 114
- Issue
- 8
- Pages
- 798-806
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2151857625
- Cited by
- 464
- References
- 25
- FWCI
- 52.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.